Kelly "Girl" Sutton Races Toward Top Five in Overall Points
NASCAR Goody's Dash Series Driver Enters Last Race of the Season

ATLANTA (October 24, 2003) –– The last time Kelly "Girl" Sutton visited the 1/4-mile track at Atlanta Motor Speedway, she was looking to cap off a successful rookie season. This year, Sutton enters the season finale with her eyes set on finishing within the top five in the Goody's Dash Series points race. Kelly "Girl" Sutton has been a model of consistency throughout the 2003 season. Ranked sixth in the overall point standings, she will be only 30 points away from her goal when she takes the green flag.

Sutton, the first person with relapsing-remitting multiple sclerosis (RRMS) known to race in any NASCAR series, will compete Friday, Oct. 24, in the final Goody's Dash Touring Series race of the season — the "Brawny 150" at Atlanta Motor Speedway. The Team COPAXONE^® (glatiramer acetate injection) driver is riding the momentum of an impressive streak, where she has finished in the top 10 or 15 in nearly every race.

"We are having an awesome season and need one more great run here at Atlanta to end it right," said a determined Sutton. "Last year, we lost the clutch in a wreck during the first part of the race and had to fight hard to finish 15th. This year we're a much stronger and faster team, and I want to be up front racing for the win," Sutton said with a smile.

Long Road to the Track
Sutton, a third-generation driver, began riding motorcycles when she was just 10 years old. At the age of 12, she graduated to racing go-carts. By the time she was 15, Sutton was making her mark in local racing — until overwhelming fatigue and a tingling sensation on her right side began sidelining her on a regular basis. At 16, Sutton was diagnosed with RRMS.

"I was devastated," said Sutton. "I was afraid I would have to give up the things I loved."

Although she did spend time in a wheelchair, Sutton was determined to learn how to manage her disease. Through a disciplined exercise regimen, a conscientious diet, and a daily injection of drug therapy, she found herself back in the driver's seat.

It was a long road, but in 2002, Sutton raced her first full season in the Goody's Dash Series, finishing third in rookie points and twelfth overall — beating out 75 other drivers.

Reaching out to Fans
Sutton's determination resonates with fans. At the 2002 Goody's Dash Series banquet, she was named the most popular driver in the series.

"Everybody has mountains to climb," says the 31-year-old mother of two. "Mine is MS. I think because I’ve battled it so publicly, people can see some of their own stories in mine."

During breaks from the racing action, Sutton travels around the country sharing with the MS community the story of her personal battle with multiple sclerosis. Sutton enjoys inspiring audiences and being inspired by them.

"Interacting with other people with MS reminds me that this disease is just something we have to deal with. It is not who we are," she says. "I am a mom. I am a wife. I am a racecar driver. Those are the things that define me — not MS."

Leaning on Science
Attitude, exercise, and diet all are important to managing MS, but in recent years, another option has emerged — drug therapy.

The FDA has approved drugs, such as the COPAXONE^® (glatiramer acetate injection) that Sutton takes. COPAXONE^® is indicated for the reduction of the frequency of relapses in relapsing-remitting MS.

The most common side effects of COPAXONE^® are redness, pain, swelling, itching, or a lump at the site of injection, flushing, chest pain, weakness, infection, pain, nausea, joint pain, anxiety, and muscle stiffness. These reactions are usually mild and seldom require professional treatment. Be sure to tell your doctor about any side effects.

Some patients report a short-term reaction right after injecting COPAXONE^®. This reaction can involve flushing (feeling of warmth and/or redness), chest tightness or pain with heart palpitations, anxiety, and trouble breathing. These symptoms generally appear within minutes of an injection, last about 15 minutes, and go away by themselves without further problems.

After you inject COPAXONE^®, call your doctor right away if you develop hives, skin rash with irritation, dizziness, sweating, chest pain, trouble breathing, severe pain at the injection site or other uncomfortable changes in your general health. Do not give yourself any more injections until your doctor tells you to begin again.

Teva Neuroscience, Inc. markets COPAXONE^®. COPAXONE^® is a registered trademark of Teva Pharmaceutical Industries Ltd. Teva Neuroscience, Inc. is a subsidiary of Teva Pharmaceutical Industries Ltd.

For more information on Kelly Sutton and her racing career, visit her Web site at www.kellygirlsutton.com.

Call 1-800-887-8100 or log onto www.copaxone.com for more information about COPAXONE^®, Team COPAXONE^®, or multiple sclerosis.

See additional important information at https://www.copaxone.com/pi/index.html
or call 1-800-887-8100 for electronic releases. For hardcopy releases, please see enclosed full prescribing information.

For More Information Contact:
Jennifer Westphal
Fleishman-Hillard
816/512-2241
[email protected]

Keith Daw
Fleishman-Hillard
816/512-2285
[email protected]